T1	p 200 265	borderline hypertensive patients with IDDM-type diabetes mellitus
T2	p 268 322	Twenty-nine IDDM patients with borderline hypertension
T3	p 1474 1520	diabetic patients with borderline hypertension
T4	i 81 120	dihydropyridine calcium channel blocker
T5	i 184 196	nitrendipine
T6	i 350 357	placebo
T7	i 361 373	nitrendipine
T8	i 386 398	Nitrendipine
T9	i 1015 1022	placebo
T10	i 1214 1226	nitrendipine
T11	i 1307 1319	nitrendipine
T12	i 1384 1396	nitrendipine
T13	o 14 44	platelet thromboxane formation
T14	o 463 504	Stimulated platelet thromboxane formation
T15	o 611 691	plasma levels of platelet factor 4 and aggregation responses to collagen and ADP
T16	o 733 754	thromboxane formation
T17	o 885 933	Exercise induced change of thromboxane synthesis
T18	o 1052 1069	PF4 plasma levels
T19	o 1112 1162	Whole blood aggregation after collagen stimulation
T20	o 1268 1279	aggregation
T21	o 1419 1457	collagen dependent platelet activation